Frederic Davi Selected Research

Immunoglobulins (Immunoglobulin)

1/2022	Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity.
11/2021	Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.
1/2021	Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders.
1/2021	Infrequent "chronic lymphocytic leukemia-specific" immunoglobulin stereotypes in aged individuals with or without low-count monoclonal B-cell lymphocytosis.
1/2019	Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
9/2017	Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
1/2016	Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.
1/2015	Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
11/2014	Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.
10/2012	Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frederic Davi Research Topics

Disease

15	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2023 - 01/2009
9	Neoplasms (Cancer) 01/2022 - 01/2002
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021 - 01/2002
3	Lymphoma (Lymphomas) 01/2019 - 12/2013
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2015 - 09/2011
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Lymphocytosis 01/2021
1	Meningitis 10/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2018
1	Disease Progression 11/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2013
1	Bacterial Infections (Bacterial Infection) 12/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2012
1	Infections 02/2012

Drug/Important Bio-Agent (IBA)

11	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2009
7	AntigensIBA 01/2019 - 01/2009
2	fludarabineIBA 11/2023 - 02/2016
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2021
2	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2019 - 10/2012
2	Interleukin-10 (Interleukin 10)IBA 10/2018 - 11/2013
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	ParaffinIBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 06/2019
1	InterleukinsIBA 10/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016
1	Rituximab (Mabthera)FDA Link 02/2016
1	Messenger RNA (mRNA)IBA 06/2015
1	Cytidine DeaminaseIBA 06/2015
1	Interleukin-10 ReceptorsIBA 11/2013
1	Terminator Codon (Termination Codon)IBA 10/2012
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 04/2004

Therapy/Procedure

3	Therapeutics 01/2018 - 05/2012
2	Organ Transplantation 02/2007 - 01/2002
1	Precision Medicine 01/2022
1	Immunotherapy 01/2022
1	Transplantation 01/2022
1	Splenectomy 02/2012
1	Drug Therapy (Chemotherapy) 01/2002